Rebecca Chambers - May 25, 2021 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role
Chief Financial Officer
Signature
By: John L Brottem For: Rebecca Chambers
Stock symbol
OM
Transactions as of
May 25, 2021
Transactions value $
-$649,991
Form type
4
Date filed
5/26/2021, 05:18 PM
Next filing
Jun 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Options Exercise $105K +16.7K +123.02% $6.25 30.3K May 25, 2021 Direct
transaction OM Common Stock Sale -$755K -16.7K -55.16% $45.11 13.6K May 25, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -16.7K -15.04% $0.00 94.5K May 25, 2021 Common Stock 16.7K $6.25 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020.
F2 The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $44.61 to $45.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 This option vests 25% on June 3, 2020 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.